S&P 500: 681.75 +0.1% NASDAQ 100: 601.92 +0.2% Dow Jones: 495.28 +0.1%

State Street SPDR S&P Biotech ETF

XBI
$122.86 $-0.319 (-0.26%)
Market Cap: $8.71 B
Gurus Holding
4
Popularity Rank
#2012
% of Shares Held
2.88%
Net Activity (Q4 2025)
+$30.5 M

Guru Ownership Trend

Guru Analysis for State Street SPDR S&P Biotech ETF (XBI)

State Street SPDR S&P Biotech ETF (XBI), a key player in the Market sector, continues to attract institutional attention.

As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $247.39 M.

Top institutional holders include Jefferies Group and Louis Moore Bacon.

Institutional sentiment is currently Bullish. This is evidenced by a $30.5 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies who opened a new position.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$30.5 M
Total Buy Value
New Buys 1
Additions 1
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
0
Net Buyers
2

FAQs for State Street SPDR S&P Biotech ETF (XBI)

Major holders include Jefferies Group ($209.12 M), Louis Moore Bacon ($25.05 M), Renaissance Technologies ($5.01 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.01 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $30.5 M, with 2 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in XBI during the most recent reporting period.

Yes, 1 managers opened new positions in XBI, and 1 increased their existing holdings. The total reported buy value was $30.5 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
1.07% Add 13.9% 1,715,089 $209.12 M Q4 2025
0.34% Add 66.7% 250,000 $25.05 M Q3 2025
0.01% New Buy 41,100 $5.01 M Q4 2025
0.00% Add 8.5% 7,388 $740,343 Q3 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form